The information on this website does not constitute an offer to sell or solicitation of an offer to buy securities by anyone in any jurisdiction which would be considered unlawful. Clear Health Pass Holdings, LLC’s offering is under Rule 506(c) of Regulation D and is considered a “safe harbor” for the private offering exemption of Section 4(a)(2) of the Securities Act. To be eligible to receive qualified investment status, you must be an accredited investor as defined by Section 2(15)(ii) of the Securities Act of 1933.

OUR TESTS

FOR INVESTORS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

FOR DISTRIBUTORS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Clear Health Pass™ is a Portfolio Partner of the Native American Venture Fund  (NAVF). Clear Health Pass Holdings, LLC, DBA Clear Health Pass™ is an appointed “tribal agent” for the Blue Lake Rancheria Economic Development Corporation (BLREDC), a Federal, Section 17, Tribal Corporation, whose tribal sovereignty is authority is derived from the Indian Reorganization Act of 1934 (IRA), 25 U.S.C. § 477. Clear Health Pass™ is a Minority / Veteran Operated Organization in Partnership as Tribal Representative with Federally Recognized Native American Tribes under 25 U.S.C. §476. Clear Health Pass™ is doing clinical trials pending pre-qual FDA submittal under its tribal status. Clear Health Pass™ is registered as Clear Health Pass Holdings, LLC and has filed with the US Securities and Exchange Commission under 506c, 144 Reg D Offering.

© 2023 Clear Health Pass Holdings, LLC., 
all rights reserved. All trademark references are trademarks of either the Clear Health Pass Holdings, LLC or their respective owners. 

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Skip to content